Cargando…
Myogenic vasoconstriction requires G(12)/G(13) and LARG to maintain local and systemic vascular resistance
Myogenic vasoconstriction is an autoregulatory function of small arteries. Recently, G-protein-coupled receptors have been involved in myogenic vasoconstriction, but the downstream signalling mechanisms and the in-vivo-function of this myogenic autoregulation are poorly understood. Here, we show tha...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777979/ https://www.ncbi.nlm.nih.gov/pubmed/31549965 http://dx.doi.org/10.7554/eLife.49374 |
_version_ | 1783456692573306880 |
---|---|
author | Chennupati, Ramesh Wirth, Angela Favre, Julie Li, Rui Bonnavion, Rémy Jin, Young-June Wietelmann, Astrid Schweda, Frank Wettschureck, Nina Henrion, Daniel Offermanns, Stefan |
author_facet | Chennupati, Ramesh Wirth, Angela Favre, Julie Li, Rui Bonnavion, Rémy Jin, Young-June Wietelmann, Astrid Schweda, Frank Wettschureck, Nina Henrion, Daniel Offermanns, Stefan |
author_sort | Chennupati, Ramesh |
collection | PubMed |
description | Myogenic vasoconstriction is an autoregulatory function of small arteries. Recently, G-protein-coupled receptors have been involved in myogenic vasoconstriction, but the downstream signalling mechanisms and the in-vivo-function of this myogenic autoregulation are poorly understood. Here, we show that small arteries from mice with smooth muscle-specific loss of G(12)/G(13) or the Rho guanine nucleotide exchange factor ARHGEF12 have lost myogenic vasoconstriction. This defect was accompanied by loss of RhoA activation, while vessels showed normal increases in intracellular [Ca(2+)]. In the absence of myogenic vasoconstriction, perfusion of peripheral organs was increased, systemic vascular resistance was reduced and cardiac output and left ventricular mass were increased. In addition, animals with defective myogenic vasoconstriction showed aggravated hypotension in response to endotoxin. We conclude that G(12)/G(13)- and Rho-mediated signaling plays a key role in myogenic vasoconstriction and that myogenic tone is required to maintain local and systemic vascular resistance under physiological and pathological condition. |
format | Online Article Text |
id | pubmed-6777979 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-67779792019-10-07 Myogenic vasoconstriction requires G(12)/G(13) and LARG to maintain local and systemic vascular resistance Chennupati, Ramesh Wirth, Angela Favre, Julie Li, Rui Bonnavion, Rémy Jin, Young-June Wietelmann, Astrid Schweda, Frank Wettschureck, Nina Henrion, Daniel Offermanns, Stefan eLife Cell Biology Myogenic vasoconstriction is an autoregulatory function of small arteries. Recently, G-protein-coupled receptors have been involved in myogenic vasoconstriction, but the downstream signalling mechanisms and the in-vivo-function of this myogenic autoregulation are poorly understood. Here, we show that small arteries from mice with smooth muscle-specific loss of G(12)/G(13) or the Rho guanine nucleotide exchange factor ARHGEF12 have lost myogenic vasoconstriction. This defect was accompanied by loss of RhoA activation, while vessels showed normal increases in intracellular [Ca(2+)]. In the absence of myogenic vasoconstriction, perfusion of peripheral organs was increased, systemic vascular resistance was reduced and cardiac output and left ventricular mass were increased. In addition, animals with defective myogenic vasoconstriction showed aggravated hypotension in response to endotoxin. We conclude that G(12)/G(13)- and Rho-mediated signaling plays a key role in myogenic vasoconstriction and that myogenic tone is required to maintain local and systemic vascular resistance under physiological and pathological condition. eLife Sciences Publications, Ltd 2019-09-24 /pmc/articles/PMC6777979/ /pubmed/31549965 http://dx.doi.org/10.7554/eLife.49374 Text en © 2019, Chennupati et al http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Cell Biology Chennupati, Ramesh Wirth, Angela Favre, Julie Li, Rui Bonnavion, Rémy Jin, Young-June Wietelmann, Astrid Schweda, Frank Wettschureck, Nina Henrion, Daniel Offermanns, Stefan Myogenic vasoconstriction requires G(12)/G(13) and LARG to maintain local and systemic vascular resistance |
title | Myogenic vasoconstriction requires G(12)/G(13) and LARG to maintain local and systemic vascular resistance |
title_full | Myogenic vasoconstriction requires G(12)/G(13) and LARG to maintain local and systemic vascular resistance |
title_fullStr | Myogenic vasoconstriction requires G(12)/G(13) and LARG to maintain local and systemic vascular resistance |
title_full_unstemmed | Myogenic vasoconstriction requires G(12)/G(13) and LARG to maintain local and systemic vascular resistance |
title_short | Myogenic vasoconstriction requires G(12)/G(13) and LARG to maintain local and systemic vascular resistance |
title_sort | myogenic vasoconstriction requires g(12)/g(13) and larg to maintain local and systemic vascular resistance |
topic | Cell Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777979/ https://www.ncbi.nlm.nih.gov/pubmed/31549965 http://dx.doi.org/10.7554/eLife.49374 |
work_keys_str_mv | AT chennupatiramesh myogenicvasoconstrictionrequiresg12g13andlargtomaintainlocalandsystemicvascularresistance AT wirthangela myogenicvasoconstrictionrequiresg12g13andlargtomaintainlocalandsystemicvascularresistance AT favrejulie myogenicvasoconstrictionrequiresg12g13andlargtomaintainlocalandsystemicvascularresistance AT lirui myogenicvasoconstrictionrequiresg12g13andlargtomaintainlocalandsystemicvascularresistance AT bonnavionremy myogenicvasoconstrictionrequiresg12g13andlargtomaintainlocalandsystemicvascularresistance AT jinyoungjune myogenicvasoconstrictionrequiresg12g13andlargtomaintainlocalandsystemicvascularresistance AT wietelmannastrid myogenicvasoconstrictionrequiresg12g13andlargtomaintainlocalandsystemicvascularresistance AT schwedafrank myogenicvasoconstrictionrequiresg12g13andlargtomaintainlocalandsystemicvascularresistance AT wettschurecknina myogenicvasoconstrictionrequiresg12g13andlargtomaintainlocalandsystemicvascularresistance AT henriondaniel myogenicvasoconstrictionrequiresg12g13andlargtomaintainlocalandsystemicvascularresistance AT offermannsstefan myogenicvasoconstrictionrequiresg12g13andlargtomaintainlocalandsystemicvascularresistance |